Alerta

TEXTILE SEAL-FORMING STRUCTURE WITH MULTIPLE CURVATURES

Resumen de: US20260325780A1

A patient interface including a seal-forming structure with a textile membrane that has at least one hole such that the flow of air at a therapeutic pressure is delivered to at least an entrance to the patient's nares and/or an entrance to the patient's mouth. The seal-forming structure is constructed and arranged to maintain the therapeutic pressure in a cavity of a plenum chamber throughout the patient's respiratory cycle, in use. The textile membrane includes a first portion that is held in a relaxed state and a second portion that is held in a taut state. The taut state of the second portion is configured to allow the seal-forming structure to include a three-dimensional shape that has multiple curvatures.

Recommendations based on continuous glucose monitoring

Resumen de: AU2026242121A1

Recommendations based on continuous glucose monitoring (CGM) are described. Given the number of people that wear CGM systems and because CGM systems produce measurements continuously, a platform that provides a CGM system may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process. In implementations, a CGM platform includes a data analytics platform that obtains glucose measurements provided by a CGM system and also obtains additional data associated with a user. The data analytics platform processes these measurements and the additional data to predict a health indicator by using models. This prediction serves as a basis for generating a recommendation, such as a message recommending the user take action or adopt a behavior to mitigate a predicted negative health condition. ep e p

METHODS AND SYSTEMS FOR CONTROLLING OXYGEN DELIVERY IN A FLOW THERAPY APPARATUS

Resumen de: US20260325773A1

The present disclosure provides for a control system for a flow therapy apparatus. The control system can control delivery of a fraction of delivered oxygen (FdO2) to a patient. The control system can maintain the FdO2 at a target level during a therapy session. The control system can automatically control an oxygen inlet valve in order to control the flow of oxygen to the patient.

SYSTEMS AND METHODS FOR COMMUNICATION WITH ANALYTE SENSOR ELECTRONICS

Resumen de: US20260325019A1

Systems and methods for wireless communication of analyte information are disclosed. Example embodiments include an analyte sensor system. The analyte sensor system may include an analyte sensor to gather information related to a level of an analyte in a host. The analyte sensor system may include circuitry to transmit and receive wireless signals using a first antenna. The analyte sensor may be coupled to the circuitry before the analyte sensor system is transitioned into an operational state. The analyte sensor system may include a second antenna to receive an input signal from a source external to the analyte sensor system and to transmit a modified signal. The circuitry may use the first antenna to receive the modified signal The analyte sensor system may transition into the operational state in response to the modified signal received using the first antenna.

REMOTE COMMUNICATIONS AND CONTROL SYSTEM FOR ROBOTIC INTERVENTIONAL PROCEDURES

Resumen de: US20260325244A1

A method for using a control center at a remote site to control operation of a robotic medical device system at a local site includes transmitting a control signal from the control center to the robotic medical device system, determining a delay in transmission of the control signal, comparing the delay to a threshold delay value and operating the robotic medical device system based on the comparison of the delay to the threshold delay value.

Quality Assurance Method, Quality Assurance Phantom and Computer-Readable Storage Medium

Resumen de: US20260331271A1

0000 The disclosure provide a quality assurance method for performing quality assurance on a radiation delivery system, the method comprising: performing a first quality assurance operation using a quality assurance phantom; and performing a second quality assurance operation using the quality assurance phantom, wherein the first quality assurance operation is one of an imaging quality assurance operation and a machine quality assurance operation, and the second quality assurance operation is the other one of the imaging quality assurance operation and the machine quality assurance operation, and between the first quality assurance operation and the second quality assurance operation, the quality assurance phantom is automatically moved from a first position corresponding to the first operation to a second position corresponding to the second operation, or remains at a fixed position.

APPARATUS AND METHOD OF DETERMINING A CARDIAC IMPLANT SIZE

Resumen de: US20260325219A1

Described herein is an apparatus and method for determining a cardiac implant size. In some embodiments, an apparatus may include an ultrasonic imaging device, at least a processor, and a memory communicatively connected to the at least a processor, wherein the memory contains instructions configuring the at least a processor to, using the ultrasonic imaging device, collect a plurality of ultrasonic images, using a 3D cardiac model generation machine learning model trained on a training dataset comprising example ultrasonic images correlated with example 3D cardiac models, generate a 3D cardiac model based on the plurality of ultrasonic images, generate at least a cardiac measurement based on the 3D cardiac model, determine a cardiac implant size based on the at least a cardiac measurement, and display to a user the cardiac implant size.

PATIENT-SPECIFIC IMPLANT DESIGN, MANUFACTURE AND PLATFORM WITH CLINICAL AND THIRD-PARTY DATA ACQUISITION

Resumen de: US20260325305A1

0000 Systems and methods for designing patient-specific orthopedic implants. The systems and methods can include automated collection protocols for available third-party data to use to generate surgical plans or patient-specific orthopedic implant designs. The system can identify triggers for collecting third-party data. The system can determine a confidence score for the collected third-party data based on the type of data, the source of the data, and the similarity of the data to patient data. The system can select parameters in the third-party data to integrate into designing a patient-specific implant or patient treatment.

PATIENT CARE SYSTEM AND METHOD OF MONITORING INJECTIONS

Resumen de: AU2025271814A1

A patient care system for monitoring injections and/or a patient's adherence to a prescribed treatment regimen comprises: an autoinjector for administering a medicament, such as a growth hormone, in particular to a patient, wherein the autoinjector is configured to receive a cartridge, in particular a dual chamber cartridge, with the medicament, wherein a dose of the medicament corresponds to a complete content of the medicament in the cartridge, wherein the cartridge comprises a code which is indicative of the dose, and wherein the autoinjector comprises a code reader for determining the code, wherein the autoinjector is further configured to administer at least approximately the complete content of the medicament in one administration, a computing device, in particular a mobile and/or a handheld computing device, wherein the autoinjector is configured to send the code which is indicative of the dose of the medicament to the computing device via a wireless or wired connection, in particular in response to or prior to the administering of the medicament, wherein the computing device is configured to store the code in conjunction with a time stamp that is either determined by the computing device or sent together with the code by the autoinjector, wherein the time stamp is indicative of the time and/or the date of the administering of the medicament and wherein the computing device is configured to store the code in conjunction with the time stamp on a storage device, which is

SYSTEM FOR CUSTOM IMPLANT DESIGN AND INSTRUMENTATION

Resumen de: AU2025254558A1

Systems and methods include a component of a bone implant that includes a patient specific bone contacting surface and, optionally, at least one protrusion adjacent to or extending from the patient specific bone contacting surface. The at least one protrusion is configured for engaging a bone preparation in the bone. To prepare the bone for receiving the component, one or more cutting tool templates may be used. The one or more cutting tool templates may be fabricated to have a patient specific bone contacting surface that engages the bone that is to receive the implant component. A cutting tool is engaged in one or more of one or more slots defined by the cutting tool template(s) to remove surface portions of the bone to create the bone preparation for engaging the protrusion. The patient specific bone contacting surface of the component engages the bone.

SYSTEM FOR MEDICINAL SUPPLY MONITORING AND MANAGEMENT

Resumen de: AU2025237721A1

A medicinal supply management system manages distribution of medicinal supply. The system may implement a pooling algorithm for pooling studies together, across different countries, with different protocol labeling parameters and/or blinding parameters. The system may allocate unique identifiers for the pooled studies. The system may implement digital display labels on the medicinal product for up-to-date presentation of relevant information to healthcare providers administering the medicinal product. The system may further implement controlled packaging for maintaining proper storage of the medicinal product, e.g., during transport to the treatment site. The controlled packaging may further include sensors for monitoring the internal environment of the controlled packaging, to maintain proper storage of the medicinal product.

A SYSTEM AND METHOD FOR SEGMENTATION AND SPLIT MOLD PRODUCTION IN THREE-DIMENSIONAL DENTAL MODELS

Resumen de: WO2026221588A2

The invention relates to an automated processing of 3D dental models to create restoration molds in the field of digital dentistry.

THREE-DIMENSIONAL (3D) BIO-PRINTED CARTILAGE ORGANOIDS AND METHOD FOR GENERATING THE SAME

Resumen de: US20260327564A1

A method for generating three-dimensional (3D) cartilage organoids through bioprinting, the method comprising: expanding mesenchymal stem cells (MSCs); preparing a composite bioink; and, bioprinting a cell-laden scaffold to generate the 3D cartilage organoids. Also disclosed is a three-dimensional (3D) cartilage organoid for use in disease modeling and screening, the organoid comprising: human multipotent mesenchymal stem cells (MSCs) and a composite bioink.

SYSTEM AND METHOD FOR NON-INVASIVE LOCALIZATION OF RIGHT VENTRICULAR ACTIVATION SITES

Resumen de: WO2026222455A1

A system includes a processor and a storage medium having encoded thereon executable instructions that, when executed by the processor, cause the processor to carry out a method. The method includes receiving surface electrocardiogram (ECG) data of a patient, translating the surface ECG data into 3D spatial coordinates on a right ventricle (RV) anatomical model, and predicting an origin of a ventricular arrhythmia (VA), based on the translated ECG data, on the RV anatomical model.

PHOTON BEAM BOLUS DESIGN METHOD FOR PHOTON BEAM RADIATION THERAPY

Resumen de: WO2026221909A1

A method for designing a photon beam bolus for use in photon beam radiation therapy includes receiving three-dimensional imaging data of a patient and delineations of anatomic regions including an external patient contour and an internal target volume. A bolus design algorithm is used to generate a bolus geometry that includes an inner surface conforming to the external patient contour, and an outer surface determined based on the internal target volume and megavoltage photon beam dose deposition characteristics to be applied to the internal target volume. A profile of the photon beam bolus defines a spatially-varying thickness between the inner surface and the outer surface.

INCORPORATION OF A FUSED DEPOSITION MODELING (FDM) PRINT HEAD INTO A HYBRID DEVICE AND METHOD FOR THE REINFORCEMENT OF POLYMER FIBER TEXTILES OR HYDROGEL STRUCTURES RENDERED BY MELT ELECTRO WRITING, ELECTROSPINNING, STANDARD BIOPRINTING, CHAOTIC BIOPRINTING, OR FDM ALONE

Resumen de: US20260326376A1

0000 A hybrid printhead apparatus and method for additive manufacturing that integrates Melt Electrowriting, Fused Deposition Modeling, and Electrospinning into a single device is provided. The disclosed embodiments utilize parallel, independently controlled linear guides to deposit delicate, high precision polymer fibers, and subsequently reinforcing them with thicker macroscale fibers. This hybrid method preserves the structural integrity of the delicate underlying meshes despite varying processing temperatures. Furthermore, the disclosed embodiments enable the incorporation of bioactive compounds, such as those derived from Opuntia ficus-indica. By altering the physical pore size of the underlying framework, the disclosed embodiments provide tunable, sustained release kinetics for advanced tissue engineering and chronic wound care.

LEFT ATRIAL APPENDAGE SEGMENTATION AND QUANTIFICATION IN 3D AND 4D CARDIAC ULTRASOUND

Resumen de: US20260330798A1

Systems and methods for real time three-dimensional left atrial appendage (LAA) quantification. Deep learning is used to perform LAA segmentation, tracking and live quantification on critical measurement in 4D ultrasound sequences. The collected information may be used for device selection and anomaly detection to assist early-phase disease finding.

DETECTING INFUSION PUMP FAILURE

Resumen de: US20260325741A1

A system and method for detecting failure of an infusion pump is disclosed. The system includes a communication module that is separate and independent of a pump operating system of the pump. The communication module periodically monitors the pump operating system to determine the operational status of the pump operating system, and establishes a failure of the pump operating system when signals are no longer detected from the pump operating system within a specific predetermined timeout interval. The communication module then communicates with a remote computing device regarding a failure to determine the operational status of the pump operating system. According to various examples, the timeout interval is determined based on predetermined technical factors associated with the infusion pump and/or clinical factors associated with a patient receiving a therapy from the infusion pump, the therapy, or a care area associated with the patient.

SYSTEM AND METHOD FOR TRANSSEPTAL PUNCTURE SITE SELECTION

Resumen de: US20260325214A1

A system and method for transseptal puncture site selection are disclosed. The system includes a processor and a memory communicatively connected to the processor, the memory containing instructions configuring the processor to receive a 3D organ model pertaining to an organ of a subject, receive a treatment plan pertaining to the subject, wherein the treatment plan includes at least an area of interest, and a procedure type, generate treatment guidance as a function of the treatment plan, and generate an overlay for the 3D organ model as a function of a puncture site and an optimized access route.

A ROUTINE MANAGEMENT SYSTEM

Resumen de: WO2026220200A1

This invention relates to a routine management system. In particular, the present invention relates to a routine management system for supporting daily scheduling and self-regulation in children with ADHD. A routine management system according to the invention is provided which comprises a physical routine planner including generally, a plurality of variable activity elements that represent discrete tasks forming part of a varying routine, a user‑wearable reminder device configured to deliver sensory‑regulating feedback to prompt a user regarding the status of tasks, while also logging compliance data, and a mobile application, in electronic communication with both the physical planner and the user-wearable reminder device, which enables the authoring, synchronization, and dynamic updating of the routine based on pre‑determined cycles to facilitate unified tangible task interaction, multisensory prompting, adaptive feedback, and multi‑party communication into a cohesive framework for enhancing self‑regulation and adherence to a routine by a user.

CHARACTERIZING AND IDENTIFYING BIOLOGICAL STRUCTURE

Resumen de: US20260331285A1

0000 Embodiments described relate to techniques for identifying and characterizing biological structures using machine learning techniques. These techniques may be employed to enable a device to identify the particular type of tissue and/or cells (e.g., platelets, smooth muscle cells, or endothelial cells) in, for example, a biological structure, which may be a tissue or a lesion of a duct (e.g., vasculature) in an animal (e.g., a human or non-human animal), among other structures. The machine learning techniques may use raw impedance spectroscopy measurement data in addition to values derived from that raw data. In addition, the machine learning techniques may be used to select frequencies at which to measure impedance and select features to extract from the measured impedance at the selected frequencies to arrive at a small set of frequencies that allow for reliable differentiation.

ADVANCED INFUSION TIMERS

Resumen de: US20260325751A1

0000 A medical timer device has processors and memory including instructions that, when executed by the processors, cause timer logic to set a timer for a delivery of a medication by intravenous infusion, to obtain an infusion variable, to calculate a time period for an operational parameter of the infusion based on the infusion variable and to generate an indicator about the operational parameter. An infusion pump and a method of using a medical timer device are also provided.

SELECTIVELY RECORDING HIGH-FIDELITY DATA BY A MEDICAL DEVICE

Resumen de: US20260325040A1

0000 An example method includes continuously recording high-fidelity data at a medical device in a circular buffer. The high-fidelity data can include physiological parameter data, user operational data, and medical device data. The method also includes detecting a trigger event. In response to detecting the trigger event, the medical device can store, in a memory associated with the medical device, a portion of the high-fidelity data corresponding to a period of time after the trigger event. The method further includes transmitting the portion of the high-fidelity data to an external device.

NANOPARTICLE-FUNCTIONALIZED ELECTROSPUN SCAFFOLDS AND USES THEREOF

Resumen de: US20260325720A1

0000 Compositions and methods of making of piezoelectric polymer scaffolds and a plurality of charged nanoparticles and methods of use thereof.

METHOD AND APPARATUS FOR PROVIDING A RADIATION TREATMENT PLAN

Nº publicación: US20260325873A1 22/10/2026

Solicitante:

SIEMENS HEALTHINEERS INT AG [CH]
Siemens Healthineers International AG

Resumen de: US20260325873A1

0000 A control circuit accesses information regarding a time-based physiological limit for the particular patient and uses that time-based physiological limit as an optimization objective. The control circuit can then automatically split a treatment trajectory for the radiation treatment plan as a function of that time-based physiological limit.